Executive Function at Risk: Androgen Deprivation Therapy, Cognitive Decline, and the Question of Fitness to Serve

Prostate cancer treatment, particularly Androgen Deprivation Therapy (ADT), has been increasingly recognized for its potential neurocognitive consequences, especially in aging populations. As survival rates improve, understanding and mitigating these effects have become critical aspects of long-term care.